Author Correction: Chemoproteomic discovery of a covalent allosteric inhibitor of WRN helicase
Nature
.
2024 Jul;631(8021):E12.
doi: 10.1038/s41586-024-07595-7.
Authors
Kristen A Baltgalvis
1
,
Kelsey N Lamb
1
,
Kent T Symons
1
,
Chu-Chiao Wu
1
,
Melissa A Hoffman
1
,
Aaron N Snead
1
,
Xiaodan Song
1
,
Thomas Glaza
1
,
Shota Kikuchi
1
,
Jason C Green
1
,
Donald C Rogness
1
,
Betty Lam
1
,
Maria E Rodriguez-Aguirre
1
,
David R Woody
1
,
Christie L Eissler
1
,
Socorro Rodiles
1
,
Seth M Negron
1
,
Steffen M Bernard
1
,
Eileen Tran
1
,
Jonathan Pollock
1
,
Ali Tabatabaei
1
,
Victor Contreras
1
,
Heather N Williams
1
,
Martha K Pastuszka
1
,
John J Sigler
1
,
Piergiorgio Pettazzoni
2
,
Markus G Rudolph
2
,
Moritz Classen
2
,
Doris Brugger
2
,
Christopher Claiborne
2
,
Jean-Marc Plancher
2
,
Isabel Cuartas
3
,
Joan Seoane
3
,
Laurence E Burgess
1
,
Robert T Abraham
1
4
,
David S Weinstein
1
,
Gabriel M Simon
1
,
Matthew P Patricelli
5
,
Todd M Kinsella
6
Affiliations
1
Vividion Therapeutics, San Diego, CA, USA.
2
Pharma Research and Early Development pRED F. Hoffmann-La Roche, Ltd, Basel, Switzerland.
3
Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, CIBERONC, Barcelona, Spain.
4
Odyssey Therapeutics, San Diego, CA, USA.
5
Vividion Therapeutics, San Diego, CA, USA. mattp@vividion.com.
6
Vividion Therapeutics, San Diego, CA, USA. tkinsella71c@gmail.com.
PMID:
38961306
DOI:
10.1038/s41586-024-07595-7
No abstract available
Publication types
Published Erratum